Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Pharmaceutical Retailersβ
2026-06-09HKPD3Form 3 Filing: Wang Zifeng's Initial Statement of Beneficial Ownership in Cellyan BiotechnologyMEDIUM
This Form 3 filing discloses the initial statement of beneficial ownership by Wang Zifeng, Chief Strategy Officer of Cellyan Biotechnology Co., Ltd (ticker: HKPD). The filing indicates that Wang Zifeng, with CIK 0002139348, reported no securities owned as of March 18, 2026. The filing was signed on June 8, 2026, and Wa...
Nano CapPharmaceutical Retailers
2026-06-08HKPD3Insider Filing - Cellyan Biotechnology Co., Ltd (HKPD)
This filing reports on a change in beneficial ownership for Cellyan Biotechnology Co., Ltd (HKPD). The reporting owner, Liang Chenyu Andy, identified by CIK 0002125293, holds the position of CEO and Director at the company. The filing indicates that the owner has no securities owned, with a reporting date of March 18, ...
Nano CapPharmaceutical Retailers